"L'Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) és un centre de recerca en biomedicina creat l'any 2004 i situat a L'Hospitalet de Llobregat. Els focus de la recerca a l’IDIBELL són el càncer, les neurociències, la medicina translacional i la medicina regenerativa. La recerca, la innovació i la societat són els pivots sobre els quals els investigadors treballen cada dia per tal de millorar la qualitat de vida dels ciutadans i ciutadanes."

During the past decade, Hospital Universitari de Bellvitge, IDIBELL conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari de Bellvitge, IDIBELL" are "Amyotrophic Lateral Sclerosis" (2 trials), "Acute Kidney Injury Due to Sepsis" (1 trials), "Depression" (1 trials) and "Early Parkinson Disease" (1 trials). Many other conditions were trialed in "Hospital Universitari de Bellvitge, IDIBELL" in a lesser frequency.

Most popular intervention types in "Hospital Universitari de Bellvitge, IDIBELL" are "Drug" (4 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMX0035" (2 trials), "Placebo" (2 trials), "C-ECT" (1 trials), "K0706" (1 trials) and "PHARMACOTHERAPY" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari de Bellvitge, IDIBELL" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitari de Bellvitge, IDIBELL". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Hospital Universitari de Bellvitge, IDIBELL, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari de Bellvitge, IDIBELL, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".